NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

West Pharmaceutical Services, Inc. (WST) Stock Analysis

West Pharmaceutical Services, Inc. (WST) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

WST

$339.97

−$2.76 (−0.81%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare WST with… →

WST Key Statistics

As of Sep 4, 2026
Trading
Open
$339.76
Previous Close
$342.73
Day's Range
339.76–342.67
52-Week Range
223.83–386.00
Volume
364.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.14
Valuation
Market Cap
$23.93B
P/E Ratio
43.87
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
34.12
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.67
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
7.19
EPS (ttm)Profit attributable to each share over the last twelve months.
7.75
Financials (FY)
Revenue (FY)
$3.07B+6.25%
Net Income (FY)
$493.70M+0.20%
Profit marginThe share of revenue left as profit after all costs and taxes.
16.98%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
70.38M
1-Year Return
+37.77%
Dividend and dates
Dividend
$0.88+0.26%
Ex-Dividend Date
July 29, 2026
Earnings Date
October 22, 2026
Avg Volume
694.39K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

WST Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+23.85%
2025−15.73%
2024−6.75%
2023+49.97%
2022−49.70%
2021+65.88%
2020+89.05%
2019+54.13%
2018−0.08%
2017+17.02%
2016 (partial year)+5.38%

As of September 4, 2026.

WST Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$3.07B$493.70M16.1%
2024$2.89B$492.70M17.0%
2023$2.95B$593.40M20.1%
2022$2.89B$585.90M20.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.07B$1.10B$636.10M$493.70M16.1%
2024$2.89B$998.50M$590.90M$492.70M17.0%
2023$2.95B$1.13B$707.40M$593.40M20.1%
2022$2.89B$1.14B$760.80M$585.90M20.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

WST Dividend History

$0.85+4.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.663—
2025$0.854+4.9%
2024$0.814+5.2%
2023$0.774+5.5%
YearDividends per sharePaymentsChange
2026 (partial year)$0.663—
2025$0.854+4.9%
2024$0.814+5.2%
2023$0.774+5.5%
2022$0.734+5.8%
2021$0.694+6.2%
2020$0.654+6.6%
2019$0.614+7.0%
2018$0.574+7.5%
2017$0.534+307.7%
2016$0.131—

Most recent payment: $0.22 per share, ex-dividend July 29, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

WST Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricWSTMedical Instruments & Supplies medianvs median
P/E43.8735.6123% above
P/S ratio7.193.17127% above
Profit margin16.98%0.85%16.1 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

West Pharmaceutical Services, Inc. (WST) is capitalised at $23.93B on the latest close. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 10,800 employees.

WST last closed at $339.97 on September 4, 2026. That is −$2.76 (−0.81%) against the previous close. The 52-week range on file runs from $223.83 to $386.00. The latest close sits 51.89% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.07B. That is +6.25% against the prior fiscal year, when revenue was $2.89B. Net income for the same year was $493.70M. That is +0.20% against the prior fiscal year. The reported profit margin is 16.98%. That is 16.1 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 7.75.

Across the 4 fiscal years on file, revenue moves from $2.89B in 2022 to $3.07B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 43.87 times earnings. That is 23.18% above the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 34.12. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.67. The price-to-sales ratio is 7.19. On price-to-sales that is 126.67% above the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 1.14. Daily returns over the trailing 10 years annualize to a volatility of 34.74%. Over the trailing twelve months the price has returned +37.77%. Across 10 years the annualized return works out at +15.42%.

Growth & Income

Shareholders receive a dividend, yielding 0.26% on the latest price. That is 0.7 percentage points below the Medical Instruments & Supplies median yield of 0.97%. At the indicated rate that is $0.88 a share a year. The ex-dividend date on file is July 29, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.66 a share. The year before, 2025, totalled $0.85 a share.

2026 is still running; the price is +23.85% year to date. The strongest complete calendar year on file is 2020 at +89.05%; the weakest is 2022 at −49.70%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

West Pharmaceutical Services, Inc. (WST) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
West Pharmaceutical Services, Inc. WST $23.93B 43.9
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. West Pharmaceutical Services, Inc. trades at a P/E of 43.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 HOLX

Hologic, Inc.

$16.97B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Visit website →